| 1 | AMGN | Amgen Inc. | 16.09% |
| 2 | GILD | Gilead Sciences, Inc. | 12.89% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 11.16% |
| 4 | NTRA | Natera, Inc. | 5.41% |
| 5 | ARGX | argenx SE | 5.32% |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | 5.31% |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.91% |
| 8 | IQV | IQVIA Holdings Inc. | 4.25% |
| 9 | BIIB | Biogen Inc. | 3.45% |
| 10 | ICLR | ICON Public Limited Company | 3.22% |
| 11 | ILMN | Illumina, Inc. | 3.07% |
| 12 | BNTX | BioNTech SE | 2.71% |
| 13 | NBIX | Neurocrine Biosciences, Inc. | 2.59% |
| 14 | INSM | Insmed Incorporated | 2.50% |
| 15 | MRNA | Moderna, Inc. | 2.19% |
| 16 | ONC | BeiGene, Ltd. | 2.05% |
| 17 | TECH | Bio-Techne Corporation | 1.87% |
| 18 | INCY | Incyte Corporation | 1.85% |
| 19 | QGEN | Qiagen N.V. | 1.78% |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 1.76% |
| 21 | EXAS | Exact Sciences Corporation | 1.72% |
| 22 | CRL | Charles River Laboratories International, Inc. | 1.64% |
| 23 | RGEN | Repligen Corporation | 1.53% |
| 24 | SRPT | Sarepta Therapeutics, Inc. | 0.78% |
| 25 | -USD CASH- | | -0.01% |
| View BBH holdings |